These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 16600350)
21. Long-term survival after combined modality treatment in metastatic bladder cancer patients presenting with supra-regional tumor positive lymph nodes only. de Vries RR; Nieuwenhuijzen JA; Meinhardt W; Bais EM; Horenblas S Eur J Surg Oncol; 2009 Apr; 35(4):352-5. PubMed ID: 18722076 [TBL] [Abstract][Full Text] [Related]
22. A model that predicts the probability of positive imaging in prostate cancer cases with biochemical failure after initial definitive local therapy. Choueiri TK; Dreicer R; Paciorek A; Carroll PR; Konety B J Urol; 2008 Mar; 179(3):906-10; discussion 910. PubMed ID: 18207194 [TBL] [Abstract][Full Text] [Related]
23. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases]. Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380 [TBL] [Abstract][Full Text] [Related]
24. Relapse after radical prostatectomy correlates with preoperative PSA velocity and tumor volume: results from a screening population. Berger AP; Deibl M; Strasak A; Bektic J; Pelzer A; Steiner H; Spranger R; Fritsche G; Bartsch G; Horninger W Urology; 2006 Nov; 68(5):1067-71. PubMed ID: 17095070 [TBL] [Abstract][Full Text] [Related]
25. Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence. Pucar D; Hricak H; Shukla-Dave A; Kuroiwa K; Drobnjak M; Eastham J; Scardino PT; Zelefsky MJ Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):62-9. PubMed ID: 17707266 [TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of proliferation activity and neuroendocrine differentiation to predict treatment failure after radical prostatectomy. May M; Siegsmund M; Hammermann F; Loy V; Gunia S Scand J Urol Nephrol; 2007; 41(5):375-81. PubMed ID: 17853019 [TBL] [Abstract][Full Text] [Related]
27. Gastrointestinal stromal tumors (GISTs) on prostate needle biopsy: A clinicopathologic study of 8 cases. Herawi M; Montgomery EA; Epstein JI Am J Surg Pathol; 2006 Nov; 30(11):1389-95. PubMed ID: 17063078 [TBL] [Abstract][Full Text] [Related]
28. Laparoscopic pelvic autonomic nerve-preserving surgery for patients with lower rectal cancer after chemoradiation therapy. Liang JT; Lai HS; Lee PH Ann Surg Oncol; 2007 Apr; 14(4):1285-7. PubMed ID: 17235719 [TBL] [Abstract][Full Text] [Related]
29. Local control and long-term disease-free survival for stage D1 (T2-T4N1-N2M0) prostate cancer after radical prostatectomy in the PSA era. Gjertson CK; Asher KP; Sclar JD; Goluboff ET; Olsson CA; Benson MC; McKiernan JM Urology; 2007 Oct; 70(4):723-7. PubMed ID: 17991544 [TBL] [Abstract][Full Text] [Related]
30. Recurrent phyllodes tumours of the breast: pathological features and clinical implications. Tan EY; Tan PH; Yong WS; Wong HB; Ho GH; Yeo AW; Wong CY ANZ J Surg; 2006 Jun; 76(6):476-80. PubMed ID: 16768772 [TBL] [Abstract][Full Text] [Related]
31. [Primary squamous cell carcinoma of the prostate: a case report]. Inaba M; Boku H; Tanaka S; Fujito A Hinyokika Kiyo; 2007 Jan; 53(1):39-41. PubMed ID: 17310767 [TBL] [Abstract][Full Text] [Related]
32. Malignant phyllodes tumor of the prostate. Wu YS; Lee SH; Shen BY; Chang PL; Tsui KH; Ng KF Arch Androl; 2005; 51(4):295-8. PubMed ID: 16036637 [TBL] [Abstract][Full Text] [Related]
33. PSA recurrence after brachytherapy for seed misplacement: a double-blind radiologic and pathologic work-up after salvage prostatectomy. Gacci M; Serni S; Lapini A; Vittori G; Vignolini G; Nesi G; Carini M Prostate Cancer Prostatic Dis; 2008; 11(1):99-101. PubMed ID: 17923856 [TBL] [Abstract][Full Text] [Related]
34. [Leiomyosarcoma of the prostate: a case report of remission for 9 years by radiotherapy]. Sakano Y; Yonese J; Okubo Y; Yoshimura K; Maeda H; Yamauchi T; Fukui I; Kawai T; Ishikawa Y Hinyokika Kiyo; 1995 Aug; 41(8):629-32. PubMed ID: 7572445 [TBL] [Abstract][Full Text] [Related]
35. [A case of ductal carcinoma of the prostate after transurethral resection of prostate]. Izumi K; Kanno H; Umemoto S; Hasumi H; Osada Y; Ota J; Tsuchiya F; Ogino I; Harada M Hinyokika Kiyo; 2007 May; 53(5):315-8. PubMed ID: 17561717 [TBL] [Abstract][Full Text] [Related]
36. Limited pelvic lymph node dissection at the time of radical prostatectomy does not affect 5-year failure rates for low, intermediate and high risk prostate cancer: results from CaPSURE. Berglund RK; Sadetsky N; DuChane J; Carroll PR; Klein EA J Urol; 2007 Feb; 177(2):526-29; discussion 529-30. PubMed ID: 17222625 [TBL] [Abstract][Full Text] [Related]
37. Transrectal high-intensity focused ultrasound for treatment for patients with biochemical failure after radical prostatectomy. Hayashi M; Shinmei S; Asano K Int J Urol; 2007 Nov; 14(11):1048-50. PubMed ID: 17956536 [TBL] [Abstract][Full Text] [Related]
38. [Preliminary results for EORTC trial 22911: radical prostatectomy followed by postoperative radiotherapy in prostate cancers with a high risk of progression]. Bolla M; Van Poppel H; Collette L; Cancer Radiother; 2007 Nov; 11(6-7):363-9. PubMed ID: 17931949 [TBL] [Abstract][Full Text] [Related]